ArticleJAC-antimicrobial resistance2026
Mapping antimicrobial resistance awareness in Canada: what are our knowledge gaps?
Article in JAC-antimicrobial resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Often referred to as a silent pandemic, antimicrobial resistance (AMR) is gradually expanding worldwide. Addressing this escalating threat requires collaborative efforts from governments, stakeholders and community members; thus, fostering widespread public knowledge is crucial. We aimed to assess the knowledge, attitudes and practices (KAPs) related to AMR in a diverse cohort from the province of Quebec, Canada, to identify critical gaps in targeted educational interventions. Methods: An observational, cross-sectional, descriptive study was conducted from April 2022 to August 2023. Participants included individuals 18 years or older from urban areas in Quebec, focusing on the cities of Montreal and Laval. The data were collected using a questionnaire adapted from the World Health Organization's 'Antibiotic Resistance: Multi-country Public Awareness Survey'. Results: The study engaged 1774 participants and revealed a fair understanding of AMR, with misconception rates varying from 9.9% to 58.3%. However, significant knowledge gaps were identified. When asked about following the recommended length of treatment and daily dosage of antibiotics, 13.8% affirmed not fully adhering. When asked if medication was stopped once symptoms started to disappear, 7.3% responded 'always' and 20.4% 'sometimes'. Additionally, 12.5% reported taking oral antibiotics without a prescription. Notably, men, younger audiences (18-34) and individuals with lower formal education were more prone to risky AMR-related behaviours. Conclusions: This study reveals significant gaps in public understanding and practices related to AMR in Quebec. Enhanced public education campaigns, stricter antimicrobial use regulations and tailored educational programmes targeting high-risk groups are recommended. An improved understanding of AMR can significantly contribute to global efforts to combat this pressing health issue.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.